NCT06416709View on ClinicalTrials.gov

Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

May 10, 2026

Study Completion Date

May 10, 2026

Conditions
Lung Injury
Interventions
DRUG

mesenchymal stem cells

Mesenchymal stem cell dose is 5×10\*7/10ml and is transplanted by intravenous infusion. The cells are used once every three days and for three times

OTHER

saline

10 ml saline is used as placebo once every three days and for three times

Trial Locations (1)

Unknown

RECRUITING

Beijing 302 Hospital, Beijing

All Listed Sponsors
collaborator

Beijing 302 Hospital

OTHER

lead

Cell Energy Life Sciences Group Co. LTD

INDUSTRY